It was a showpiece that held the football world in its grip, the tension mounting exponentially, everything on the line. For Paris Saint-Germain, there was the opportunity to make it clear that this is a dynastic team; the rarity of retaining a Champions League title. For Arsenal, it was simple. Never mind the Invincibles. They stood to be immortal, a first triumph in this competition to follow th...
It was a showpiece that held the football world in its grip, the tension mounting exponentially, everything on the line. For Paris Saint-Germain, there was the opportunity to make it clear that this is a dynastic team; the rarity of retaining a Champions League title. For Arsenal, it was simple. Never mind the Invincibles. They stood to be immortal, a first triumph in this competition to follow their first Premier League triumph in 22 years; the thing that has changed everything about the mood around the club. Continue reading...
Wall Street analysts have to answer to their bosses every day, which can make it hard to take a long-term view of a business. How do you justify a buy rating on a company when its stock is underperforming, and its business is struggling? That's the quandary that analysts face today with Pfizer (NYSE: PFE) . There are 29 analysts with ratings on the company. Only 2 have it as a strong buy, with ano...
Wall Street analysts have to answer to their bosses every day, which can make it hard to take a long-term view of a business. How do you justify a buy rating on a company when its stock is underperforming, and its business is struggling? That's the quandary that analysts face today with Pfizer (NYSE: PFE) . There are 29 analysts with ratings on the company. Only 2 have it as a strong buy, with another nine at buy. The rest have Pfizer at a hold, underperform, or sell. In other words, the overall Wall Street perception of the company is negative, with more than 60% suggesting investors take a cautious view of the highly respected drug company. Contrarian investors should see this as a sign to consider buying the stock. Image source: Getty Images. Continue reading
Meta is spending between $125 billion and $145 billion on AI infrastructure in 2026. Its free cash flow fell from $26 billion in Q1 last year to $1.2 billion in Q1 this year. Investors have been asking the same question ever since: what happens if all that compute does not get used fast enough? ...
Meta is spending between $125 billion and $145 billion on AI infrastructure in 2026. Its free cash flow fell from $26 billion in Q1 last year to $1.2 billion in Q1 this year. Investors have been asking the same question ever since: what happens if all that compute does not get used fast enough? ...
Artificial intelligence (AI) pioneer Nvidia is having an underwhelming 2026 so far despite delivering outstanding results quarter after quarter. Shares of the chipmaker have appreciated only 12% this year, well below the 74% jump in the PHLX Semiconductor Sector index. However, shares of Lumentum Holdings (NASDAQ: LITE) and Applied Materials (NASDAQ: AMAT) have been flying high in 2026. While Lume...
Artificial intelligence (AI) pioneer Nvidia is having an underwhelming 2026 so far despite delivering outstanding results quarter after quarter. Shares of the chipmaker have appreciated only 12% this year, well below the 74% jump in the PHLX Semiconductor Sector index. However, shares of Lumentum Holdings (NASDAQ: LITE) and Applied Materials (NASDAQ: AMAT) have been flying high in 2026. While Lumentum stock has gained 121% this year, Applied Materials has also jumped by an impressive 67%. Both companies have benefited from massive investments in AI infrastructure . Let's take a closer look at the reasons why these two stocks have been in fine form on the market so far this year and check why they are likely to deliver more upside. Continue reading
We just covered the 12 Best Stocks to Invest In According to Jim Simons’ Renaissance Technologies and Micron Technology, Inc. (NASDAQ:MU) ranks 5th on this list. Micron Technology, Inc. (NASDAQ:MU) has featured intermittently in the 13F portfolio of Renaissance Technologies. The fund first disclosed a stake in the company back in the first quarter of […]
We just covered the 12 Best Stocks to Invest In According to Jim Simons’ Renaissance Technologies and Micron Technology, Inc. (NASDAQ:MU) ranks 5th on this list. Micron Technology, Inc. (NASDAQ:MU) has featured intermittently in the 13F portfolio of Renaissance Technologies. The fund first disclosed a stake in the company back in the first quarter of […]
Kenyan Court Rejects Plan For US Ebola Quarantine Center Amid Growing Outbreak Authored by Brett Wilkins via Common Dreams A day after US officials said Kenya had approved a request to open a quarantine center for Americans exposed to a rare strain of the Ebola virus, a court in the East African nation on Friday temporarily blocked the plan amid a growing outbreak in neighboring Uganda and the Dem...
Kenyan Court Rejects Plan For US Ebola Quarantine Center Amid Growing Outbreak Authored by Brett Wilkins via Common Dreams A day after US officials said Kenya had approved a request to open a quarantine center for Americans exposed to a rare strain of the Ebola virus, a court in the East African nation on Friday temporarily blocked the plan amid a growing outbreak in neighboring Uganda and the Democratic Republic of Congo. The High Court prohibited the Kenyan government from establishing or operating any Ebola exposure, quarantine, isolation, or treatment facility in the country under any agreement with the United States or any other foreign government or agency . Getty Images The court also blocked Kenya’s government from allowing anyone infected with or exposed to Ebola into the country pending the outcome of the case, which was filed by the Katiba Institute, a civil rights group. “At its core, the case is about preserving constitutional accountability, protecting public health, and ensuring that no government may place expediency above the lives and safety of the people of Kenya,” Katiba Institute executive director Nora Mbagathi said Thursday. A 50-bed Ebola quarantine center was set to open Friday at Laikipia Air Base in Nanyuki, located approximately 125 miles north of Nairobi. The facility would have been operated by members of the US Public Health Service , a uniformed branch of the Department of Health and Human Services . US Secretary of State Marco Rubio said Thursday during a Cabinet meeting that “we cannot and will not allow any cases of Ebola to enter the United States.” However, US public health officials strongly criticized the plan to quarantine Americans in Kenya instead of repatriating them, with one emergency physician accusing the Trump administration of “a dramatic abdication of what we owe our own.” Elected leaders in Laikipia County welcomed the High Court’s ruling. They had opposed the US quarantine center, and had asked in a joint statement...
Intel (NasdaqGS:INTC) and 3DGS plan a new substrate manufacturing plant in India with a reported investment of US$3.3b. The facility is aimed at expanding advanced semiconductor packaging capacity and diversifying the global chip supply chain. The project is supported by Indian government incentives and is expected to create thousands of high skilled jobs. For you as an investor, this move sits at...
Intel (NasdaqGS:INTC) and 3DGS plan a new substrate manufacturing plant in India with a reported investment of US$3.3b. The facility is aimed at expanding advanced semiconductor packaging capacity and diversifying the global chip supply chain. The project is supported by Indian government incentives and is expected to create thousands of high skilled jobs. For you as an investor, this move sits at the intersection of Intel's core chip business and the broader push to spread manufacturing...